Target intelligence / Profile preview

G protein alpha s subunit (Gαs or Gs alpha)

Target
Gαs or Gs alpha
Molecular classification
G protein alpha subunit, Signal transduction protein, Guanine nucleotide-binding protein, Component of heterotrimeric G proteins
01

Overview

The **G protein alpha s subunit (Gαs)** is a signaling protein that functions as the stimulatory alpha subunit of heterotrimeric G proteins. It plays a central role in mediating the cellular response to various hormones and neurotransmitters that signal through G protein-coupled receptors (GPCRs). Upon ligand binding to a GPCR, Gαs exchanges GDP for GTP, dissociates from Gβγ subunits, and activates adenylyl cyclase, leading to the production of cyclic AMP (cAMP). This pathway regulates numerous physiological processes, including metabolism, endocrine function, and neural signaling[4][5][10]. Mutations in the gene encoding Gαs (GNAS) are implicated in several diseases, and aberrant regulation can be exploited by bacterial toxins such as cholera toxin. Gαs is a validated signaling target but not a therapeutic target in the sense of having specific, clinically approved drugs that directly target it as a principal mode of action; most drug interventions modulate Gαs indirectly via GPCRs.

Other names
Gs protein alpha subunitGs alpha subunitGsαGNAS proteinAdenylate cyclase-stimulatory G protein alpha subunit
02

Mechanism of action

Activation of membrane-bound adenylyl cyclase, increasing cAMP and activating downstream effectors such as protein kinase A (PKA) Drugs or toxins can act as agonists or antagonists via their receptors, altering Gsα-mediated responses

03

Biological functions

Signal transductionActivation of adenylyl cyclaseRegulation of cAMP (cyclic AMP) productionMediation of GPCR (G protein-coupled receptor) signaling
04

Disease associations

Endocrine disorders (e.g., pseudohypoparathyroidism)CancerGenetic disorders (e.g., McCune-Albright syndrome)Metabolic diseasesNeurological disorders
05

Safety considerations

Aberrant activation (e.g., by toxins or mutations) may cause hyperactive cAMP signaling, hormone resistance, tumorigenesis, or abnormal tissue growthTargeting G proteins directly can have broad effects due to ubiquity in cell signalingOff-target effects via multiple hormonal and neurotransmitter systems
06

Interacting drugs

Cholera toxin (activates Gsα by ADP-ribosylation)

1 more in the full profile.

07

Biomarkers

GNAS mutations detected in tumors (diagnostic or prognostic utility)cAMP levels as a readout of signaling activity

Beyond the preview

Go deeper on G protein alpha s subunit (Gαs or Gs alpha).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein alpha s subunit (Gαs or Gs alpha).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call